# Biomarin Pharmaceutical Inc: Form DEF 14A, filed Apr 21, 2026

- Company: [Biomarin Pharmaceutical Inc](/companies/bmrn.md) (CIK 1048477)
- Form: DEF 14A
- Filed: 2026-04-21
- Accepted by EDGAR: Apr 21, 2026, 20:19 ET
- Period: 2026-06-02
- Accession: 0001628280-26-026290
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm

Filed Apr 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-026290. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.